Bill
Bill > HB4252
MI HB4252
MI HB4252Health: pharmaceuticals; labeling of generic name on pharmaceutical blister packaging; require under certain circumstances. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding sec. 17748g.
summary
Introduced
03/18/2025
03/18/2025
In Committee
03/18/2025
03/18/2025
Crossed Over
Passed
Dead
Introduced Session
103rd Legislature
Bill Summary
A bill to amend 1978 PA 368, entitled"Public health code,"(MCL 333.1101 to 333.25211) by adding section 17748g.
AI Summary
This bill requires pharmaceutical manufacturers to include the generic name of a drug on either each blister cell or the backing of a blister pack when distributing drugs (excluding controlled substances) in Michigan. Specifically, if a drug is packaged in a blister pack with individual perforated cells, the generic name must be printed on each cell. If the blister pack does not have perforated cells, the generic name must be printed on the backing of the pack. This labeling requirement aims to provide clearer information to consumers about the medication they are taking, helping them easily identify the drug by its non-brand name. The bill amends the Public Health Code by adding a new section (17748g) to mandate this labeling practice for drug manufacturers operating in the state.
Committee Categories
Government Affairs
Sponsors (7)
Veronica Paiz (D)*,
Erin Byrnes (D),
Alabas Farhat (D),
Sharon MacDonell (D),
Mike McFall (D),
Helena Scott (D),
Stephanie Young (D),
Last Action
Bill Electronically Reproduced 03/18/2025 (on 03/19/2025)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://legislature.mi.gov/Bills/Bill?ObjectName=2025-HB-4252 |
| BillText | https://legislature.mi.gov/documents/2025-2026/billintroduced/House/htm/2025-HIB-4252.htm |
Loading...